Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Mar
8
2018
An analysis of the DCMS Select Committee Report: ‘Combatting doping in sport’ Part 2 – “British Cycling and Team Sky” Squire Patton Boggs (US) LLP
Nov
24
2021
Opioid Update: Jury Verdict Reached Against Defendant Pharmacies in Opioid MDL Squire Patton Boggs (US) LLP
Aug
24
2022
Federal Court Rejects Terms in Franchise Agreement Retaining Data Access Rights As Sufficient to Plead Section 15(b) BIPA Claim Squire Patton Boggs (US) LLP
Jul
26
2019
Beyond Surprise Billing: Lower Health Care Costs Act of 2019 Squire Patton Boggs (US) LLP
Sep
12
2019
Opioid Update: Ohio Asks Sixth Circuit for Mandamus while U.S. Chamber Says Muni Suits by Plaintiffs’ Firms Could Upend Civil Litigation Squire Patton Boggs (US) LLP
Sep
11
2015
HRSA “Drops” its Latest 340B Omnibus Guidance – Don’t Stop Believin’ in Drug Discounts Squire Patton Boggs (US) LLP
Dec
9
2015
Problem with Palm Oil (Or, Next Wave of Supply Chain Class Actions?) Squire Patton Boggs (US) LLP
Dec
5
2019
TCPA Class Melts Under Sweltering Scrutiny: Company-Wide Training Policy and Plaintiff’s “Distressing” Ignorance of Her Claim Against Ice Cream Company Defeats Typicality and Adequacy Squire Patton Boggs (US) LLP
Dec
13
2019
Absolute Liquor Liability Exclusion Is Not Illusory Squire Patton Boggs (US) LLP
May
31
2023
South Korea Looks to Tighten Biometrics Laws Amid Generative AI Squire Patton Boggs (US) LLP
Jan
7
2020
Veganism as a Protected Belief – Putting Flesh on the Bones for UK Employers Squire Patton Boggs (US) LLP
Feb
11
2020
January Update: Key Developments in UK and EU Environment, Safety and Health Law, Procedure and Policy Squire Patton Boggs (US) LLP
May
1
2020
Opioid Update: Judge Kethledge Reclaims Solitude—and Civil Procedure Squire Patton Boggs (US) LLP
Apr
9
2024
The Italian DPA Has Its Eyes on Biometric IDs – Another Fight on Tech or a Win for Privacy? Squire Patton Boggs (US) LLP
Mar
13
2017
Medical Devices, Trade Talks, Medicine Manufacturing: EU Public Policy March 13 Update Squire Patton Boggs (US) LLP
Mar
27
2017
President Trump Talks Trade in Agriculture Proclamation; Sonny Perdue Finally Gets Senate Spotlight Squire Patton Boggs (US) LLP
Apr
3
2017
Gottlieb Confirmation Hearing Set for April 5; CMS Issues Final Rule on Medicaid DSH Payments; Home Health CoPs Delayed; MedPAC Meetings This Week Squire Patton Boggs (US) LLP
Apr
12
2017
OSHA Delays Effective Date of Controversial Rule Regulating Occupational Exposure to Beryllium Squire Patton Boggs (US) LLP
Jan
12
2021
WARNING: California Prop 65 Enforcement of THC Listing from CBD Products Became Effective January 3, 2021 Squire Patton Boggs (US) LLP
Mar
27
2018
Good Corporate Social Practices: A Look at Unilever’s Supply Chain Transparency Squire Patton Boggs (US) LLP
May
18
2018
House Ways and Means Committee Advances Opioid Bills Squire Patton Boggs (US) LLP
Jun
14
2018
World Anti-Doping Code: Not Guerrero’s (World) Cup of Tea Squire Patton Boggs (US) LLP
May
6
2022
UK Government Publishes Guidance on The Implementation of The Food (Promotion and Placement) Regulations 2021 Squire Patton Boggs (US) LLP
Aug
30
2022
Perspectives on the Evolving Regulatory Landscape for US Food and Beverage Squire Patton Boggs (US) LLP
Jul
23
2019
When it comes to Opioids, DOJ’s Gloves are Off Squire Patton Boggs (US) LLP
Nov
4
2019
Nothing Cheesy About Needing to Allege Personal Injury for Coverage Squire Patton Boggs (US) LLP
Nov
11
2015
Food Law Enforcement in UK: Official Statistics 2014/ 2015 and Database of Prosecutions Squire Patton Boggs (US) LLP
Jan
21
2016
Microdosing: Silicon Valley’s Risky Race for Enhanced Workplace Creativity and Productivity Squire Patton Boggs (US) LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins